Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Springfield, IL
NPI: 1235128109Primary Practice Location
MEMORIAL MEDICAL CENTER
701 N 1st St, Springfield, IL
Primary Employer
SIU Healthcare
siumed.org
HQ Phone
Get M.D. Krishna's Phone NumberMobile
Get M.D. Krishna's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 101 | 132 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 79 | 112 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 54 | 131 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 39 | 57 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 35 | 65 |
Characterization of immortalized human mammary epithelial cell line HMEC 2.6.
Authors: Joshi, Pooja S, Modur, Vishnu, Cheng, JiMing, Robinson, Kathy, Rao, Krishna
Journal: Tumour Biol
Authors: Rao, Krishna, Bryant, Eileen, O'Hara Larivee, Siobhan, McDougall, James K
Journal: Cancer Lett
Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guérin for patients with high-risk non-muscle invasive bladder cancer.
Authors: Sherjeel Sana
Publication Date: 2019-07-20
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: everolimus, DRUG: CB-839
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: OTHER: Blood Sample Collection
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Cabozantinib S-malate
